Abstract Details

Title Temozolomide (TMZ) and Methotrexate (MTX) for Initial Treatment of Primary Central Nervous System Lymphoma (PCNSL) in the Elderly

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Antonio M. Omuro, MD, FAAN (Stanford University)	Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
Yehya A. Seddeq, MD	No disclosure on file
Luc Taillandier, MD (Hopital Saint Julien)	No disclosure on file
	No disclosure on file
	No disclosure on file
Ahm M. Huq, MBBS, PhD (Children Hospital of Michigan)	Dr. Huq has nothing to disclose.
	No disclosure on file
Khe Hoang-Xuan, MD	No disclosure on file

��ɫ��